Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 14:55:21 GMT 2023
by
admin
on
Sat Dec 16 14:55:21 GMT 2023
|
Protein Sub Type | |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
2HLC17MX9G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29726
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
||
|
FDA ORPHAN DRUG |
47190
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/00/003
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
REPLAGAL (AUTHORIZED: FABRY DISEASE)
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
||
|
WHO-ATC |
A16AB03
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
||
|
WHO-VATC |
QA16AB03
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
||
|
FDA ORPHAN DRUG |
601617
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
||
|
FDA ORPHAN DRUG |
58691
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
||
|
FDA ORPHAN DRUG |
112998
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2HLC17MX9G
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
Agalsidase Alfa
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
m5636
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
LL-03
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
104138-64-9
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
GENERIC (FAMILY) | |||
|
259351
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
C74209
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL2108214
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
9025-35-8
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
ALTERNATIVE | |||
|
5021
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
100000092056
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
8048
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
C416903
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
232-792-0
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY | |||
|
SUB12456MIG
Created by
admin on Sat Dec 16 14:55:21 GMT 2023 , Edited by admin on Sat Dec 16 14:55:21 GMT 2023
|
PRIMARY |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_108 |
N | 1_161 |
N | 1_184 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
PRODUCTION SOURCE | BIOLOGICAL |
|
||||
MOL_WEIGHT:APPROXIMATE | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|
||||
Biological Half-life | PHARMACOKINETIC |
|
|
|||